scholarly journals Rudolf Virchow and the Discovery of Cerebral Embolism

Stroke ◽  
2021 ◽  
Vol 52 (6) ◽  
Author(s):  
Jonathan Leicester
Keyword(s):  
Cerebral Embolism ◽  
Cerebral Thrombosis

This article describes the project that led Virchow to his discovery of cerebral embolism as a cause of stroke, made during the 1840s, at the beginning of his remarkable career. It includes comment on Virchow’s statements on cerebral thrombosis and stroke.

Anticoagulants and Cerebral Embolism

JAMA ◽  
1968 ◽  
Vol 203 (1) ◽  
pp. 59 ◽  
Author(s):  
Frederic Reichel
Keyword(s):  
Cerebral Embolism

Adhesive Platelet Count and Blood Coagulability in Myocardial Infarction and Cerebral Thrombosis

1970 ◽  
Vol 24 (03/04) ◽  
pp. 450-460 ◽  
Author(s):  
H Yamazaki ◽  
T Odakura ◽  
K Takeuchi ◽  
T Sano
Keyword(s):  
Myocardial Infarction ◽  
Platelet Count ◽  
Malignant Tumors ◽  
Total Cholesterol Level ◽  
Statistical Significance ◽  
Acute Stage ◽  
Cerebral Thrombosis ◽  
Prothrombin Activity ◽  
Recovery Stage ◽  
Blood Coagulability

SummaryIn 382 patients, aged 21 to 76 years, including 39 healthy volunteers, a platelet count by Olef’s method, an adhesive platelet count by Moolten-Vroman’s method, prothrombin activity due to one-stage prothrombin time and calcium clotting time were measured. In 39 cases of myocardial infarction and 40 cases of cerebral thrombosis, both in acute stage, a marked decrease in the adhesive platelet count and adhesive index and an increase of prothrombin activity were observed with statistical significance compared to the healthy group (P < 0.01). In the recovery stage of myocardial infarction, cerebral thrombosis and other diseases, except for malignant tumors, acute infectious diseases, diabetes mellitus and blood or liver diseases, the above observations were absent or reduced. In the case of thrombosis, a negative correlation was seen between the adhesive platelet count and prothrombin activity (r — —0.238, P < 0.01). There is no correlation between the changes in platelet adhesiveness or blood coagulability and total cholesterol level in serum.

scholarly journals Utility of transcranial color flow imaging for detecting high risk morphology of patent foramen ovale in patients with cerebral infarction

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
S Chino ◽  
Y Mochizuki ◽  
E Toyosaki ◽  
M Ota ◽  
K Mizuma ◽  
...  
Keyword(s):  
High Risk ◽  
Patent Foramen Ovale ◽  
Cerebral Embolism ◽  
Flow Imaging ◽  
Foramen Ovale ◽  
Color Flow ◽  
Color Flow Imaging ◽  
Bubble Test ◽  
Micro Bubble ◽  
Group B

Abstract Background Micro-bubble test by using transcranial color flow imaging (TCCFI) is important as a screening evaluation for diagnosis of paradoxical cerebral embolism which requires the proof of right to left shunt at atrial septum. In addition, high risk features of patent foramen ovale (PFO) that may allow thrombus to easily pass through the PFO itself were previously reported. However, little is known about the association between the degrees on micro-bubble test by TCCFI and the features of high risk PFO. Purpose Our aim is to clarify the relationship between the degree of micro-bubble test in TCCFI and the morphology of PFO from transesophageal echocardiography (TEE). Methods Seventy-seven patients in whom cardiogenic embolism was strongly suspected by neurologists in Showa University from April to December in 2019 were retrospectively studied. 55 patients underwent both TCCFI and TEE with sufficient Valsalva stress. TCCFI grade of micro-bubble test was classified into 3 groups (A: none, B: small, and C: massive), in which signified “none” is no sign of micro-embolic signals (MES) within 30 seconds, “small” is 1 or more MES, and “massive” is so much MES look like a curtain (Figure). Evaluated high risk characteristics of PFO for cerebral embolism as previously reported were as follows; (1) tunnel height, (2) tunnel length, (3) total excursion distance into right and left atrium, (4) existence of Eustachian valve or Chiari network, (6) angle of PFO from inferior vena cava (7) large shunt (20 or more micro-bubbles). Results Of all TCCFI-positive patients (n=32; Group B=19, Group C=13) with cerebral embolism, PFOs were detected in 23 patients in TEE. Therefore, the sensitivity and specificity of TCCFI to PFO were 87% and 63% (AUC=0.75, p&lt;0.001, respectively). Interestingly, all 13 patients (Group C) had manifest PFOs. Moreover, group C include 2 patients with platypnea orthodeoxia syndrome in which hypoxia in the sitting position becomes apparent. Among PFO-positive patients, tunnel height, length, total excursion distance into right and left atrium, and large shunt in TEE were significantly larger in Group C than Group B (p&lt;0.05). Conclusions Micro-bubble test by using TCCFI may have screening advantages in predicting paradoxical cerebral embolism, high-risk morphology of PFO, and platypnea orthodeoxia syndrome. Figure 1 Funding Acknowledgement Type of funding source: None

Antithrombin III, Heparin Cofactor and Antifactor Xa in Relation to Age, sex And Pathological Conditions

1979 ◽  
Author(s):  
F. Panicucci ◽  
A. Sacripanti ◽  
E. Pinori ◽  
M. Vispi ◽  
B. Conte ◽  
...  
Keyword(s):  
Oral Contraceptive ◽  
Antithrombin Iii ◽  
Normal Subjects ◽  
Cerebral Thrombosis ◽  
Positive Correlation ◽  
Pathological Conditions ◽  
At Iii ◽  
The Mean ◽  
Antifactor Xa ◽  
Cofactor Activity

Determinations of AT-III activity, heparin cofactor activity, antifactor Xa activity and AT-III protein were carried out in 200 healthy adults, evenly distributed within age and sex groups, in 60 patients with cerebral thrombosis and in 20 oral contraceptive users. There was a positive correlation between AT-III protein and its activitiesin normal subjects and in patients with cerebral thrombosis. In oral contraceptive users the positive correlation was between AT-III protein and its activities, antifactor Xa activity excepted. The mean AT-III protein and heparin cofactor activity values decreased in males with age and were significantly lower in the groups between 50 and 70 years. The mean AT-III protein and heparin cofactor activity values decreased slightly in women in fertile age and were lower in the 40 to 50 age-group. The mean AT-III protein and its activities values did not show any variation in the patients with cerebral thrombosis. The mean antifactor Xa activity value in the women, taking the pill for 3 months, decreased, whereas the other AT-III activities and AT-III protein were unchanged.

scholarly journals Management of cerebral embolism of cardiac origin.

Stroke ◽  
1980 ◽  
Vol 11 (5) ◽  
pp. 433-442 ◽  
Author(s):  
J D Easton ◽  
D G Sherman
Keyword(s):  
Cerebral Embolism

Cerebral embolism and atrial septal aneurysm

1998 ◽  
Vol 52 (7-8) ◽  
pp. 325
Author(s):  
G. Ruotolo ◽  
P. Gareri ◽  
G. Muccari ◽  
N. Greco ◽  
S. Mazzuca
Keyword(s):  
Cerebral Embolism ◽  
Atrial Septal Aneurysm
Sign in / Sign up

Export Citation Format

Share Document